DexCom (WBO:DXCM) FFO per Share


WBO:DXCM DexCom Inc WBO:DXCM
92 GF Score
Price €65.00
GF Value €90.32
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom FFO per Share?

FFO per Share only applies to REITs.

WBO:DXCM
92GF Score
DexCom Inc WBO:DXCM
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DexCom (WBO:DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of €65.00 is trading 28% below its estimated GF Value™ of €90.32. GuruFocus considers DexCom to be Modestly Undervalued.

Key valuation signals for WBO:DXCM:

  • FFO per Share:
  • GF Value™: €90.32 vs. price of €65.00 (28% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the WBO:DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
92GF Score

Get the complete analysis for WBO:DXCM

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price
€90.32
GF Value